The aim of this study was to compare the long-term outcome of platinum chromium-based everolimus-eluting stents (ptcr-ees) vs.Cobalt chromium-based zotarolimus-eluting stents (cocr-zes) in (b)(6).3755 patients were included in the study.Resolute integrity rx stents were implanted in 1252 of the population.Intensified and dual antiplatelet therapy was given as recommended in most patients.Patients implanted with the resolute integrity rx des were assessed 3 years post implantation.Clinical outcomes reported in the study population included death, myocardial infarction, tvr, restenosis, stent thrombosis, stroke and hemorrhage.No information was available about the cause of cardiac death.It was noted that the resolute integrity rx and non-medtronic dess had similar and excellent long-term outcomes in both efficacy and safety after pci in an all-comer east asian population.
|